Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-02-02 Option Award |
2022-02-04 6:09 pm |
N/A 2032-02-02 |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
40,000 | $0 | 40,000 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:30 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
24,606 | $4.15 | 146,287 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:30 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
38,915 | $2.94 | 146,287 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:30 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
8,265 | $4.51 | 146,287 (Direct) |
View |
| 2022-01-18 Exercise |
2022-01-20 4:30 pm |
N/A 2028-08-08 |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
71,786 | $0 | 146,287 (Direct) |
View |
Ownership |
2021-03-25 8:14 pm |
N/A N/A |
Ikena Oncology Inc. | IKNA | Tessier Maude Chief Business Officer |
0 | $0 | 281,466 (Direct) |
View |